Collaborative analysis reveals circulating IGF-I increases the risk of overall and aggressive prostate cancer in men, highlighting insulin-like growth factors as potential targets.
These findings support the role of IGF-I in the development of prostate cancer, including for aggressive disease.
No takes yet. Share an insight, caveat, or question.
Watts et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: